Skip to main content
. 2022 Aug 28;19(8):575–582. doi: 10.11909/j.issn.1671-5411.2022.08.003

Table 3. The OR and 95% CI of high SYNTAX score for lung cancer in total patients and subgroup patients stratified by NLR.

Model Total patients (n = 384) Patients with NLR-high (n = 190*) Patients with NLR-low (n = 190*)
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
*Presented as the number of patients was for those who had NLR value. Model 1: not adjusted for any variables. Model 2: adjusted for gender, age and body mass index. Model 3: adjusted for variables in model 2 plus smoking and cancer family history. Model 4: adjusted for variables in model 3 plus hypertention, diabetes mellitus and hyperlipidemia. CI: confidence interval; NLR: neutrophil-to-lymphocyte ratio; OR: odds ratio.
Model 1 1.871 1.129–3.101 0.015 2.475 1.282–4.779 0.007 1.095 0.455–2.635 0.839
Model 2 1.821 1.074–3.090 0.026 2.694 1.356–5.350 0.005 0.865 0.340–2.199 0.760
Model 3 1.810 1.059–3.092 0.030 2.932 1.447–5.940 0.003 0.812 0.318–2.070 0.662
Model 4 1.834 1.063–3.162 0.029 2.801 1.355–5.794 0.005 0.897 0.346–2.232 0.823